my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
08-11-2007: Genizon BioSciences Inc. and Neuropsychiatrie, Decouverte & Innovation Inc. (NDEI) announced an
agreement under which the groups will collaborate to enhance and potentially add to discoveries made by Genizon early this year in a genome-wide association study of schizophrenia. Genizon's study identified multiple genes associated with the disease using DNA samples from patients from the Quebec Founder Population.
NDEI, under the leadership of Dr. Michel Maziade, president of NeuroCite, scientific director of the Centre de recherche Universite Laval Robert-Giffard (CRULRG) and professor of Psychiatry at the University of Laval, will be supplying a second set of samples collected from the Quebec Founder Population. Genotyping of these samples and statistical analyses of the data will be conducted at Genizon's St. Laurent, Quebec research center.
"We are delighted to be working with Dr. Maziade and his group," said Dr. John Hooper, President and CEO of Genizon. "They have advanced expertise in schizophrenia research, and this collaboration has significant potential to enhance our discoveries in this disease."
Genizon has conducted eight genome-wide association studies to date, covering a range of therapeutic areas. All studies have used samples from the Quebec Founder Population which, because of its high level of genetic homogeneity, is considered among the best populations worldwide for disease gene discovery.
Genizon and NDEI are dedicated to accelerating the development of diagnostic and therapeutic solutions to schizophrenia.
Watchlist
This is where you can add this news to your personal favourites
Genizon BioSciences Collaborating with NDEI to Enhance Gene Discovery Findings in Schizophrenia
Genizon BioSciences Inc. and Neuropsychiatrie, Decouverte & Innovation Inc. (NDEI) announced an agreement under which the groups will collaborate to enhance and potentially add to discoveries made by Genizon early this year in a genome-wide association study of schizophrenia. Genizon's stud ... more
Genizon BioSciences Publishes Novel Genes for Crohn's Disease
Genizon BioSciences announced publication in Proceedings of the National Academy of Sciences of four novel loci in Crohn's disease, in addition to confirmation of three known Crohn's disease genes. These discoveries are derived from a genome-wide association study in the Quebec Founder Popu ... more
Genizon BioSciences announced a license and collaboration agreement with Pfizer Inc. for diagnostic rights to Genizon's discovery programs in Alzheimer's disease, attention deficit hyperactivity disorder and endometriosis. Genizon retains therapeutic rights. Under the terms of the agreemen ... more
Genizon BioSciences Inc., founded in 1999, is the only source for GeneMaps-comprehensive maps of genes, genetic markers, biochemical pathways and drug targets that are unequivocally involved in causing human disease-accelerating the development of safer, more effective medicines. GeneMaps a ... more
Genizon BioSciences Collaborating with NDEI to Enhance Gene Discovery Findings in Schizophrenia
Genizon BioSciences Inc. and Neuropsychiatrie, Decouverte & Innovation Inc. (NDEI) announced an agreement under which the groups will collaborate to enhance and potentially add to discoveries made by Genizon early this year in a genome-wide association study of schizophrenia. Genizon's stud ... more
Neuropsychiatrie, Decouverte & Innovation Inc. (NDEI)
NDEI, a spin-off company of the Centre de recherche Universite Laval Robert-Giffard (CRULRG) is in the foreground of psychiatric genomic research. Our mission is: to perform genetic and medical research to identify disease genes, and drug and diagnostic targets for neuropsychiatric disorde ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
